| Unique ID issued by UMIN | UMIN000057436 |
|---|---|
| Receipt number | R000065623 |
| Scientific Title | A Comparative Study of Anterior and Posterior Scales in a Questionnaire for the Assessment of Premenstrual Syndrome (PMS) |
| Date of disclosure of the study information | 2025/03/31 |
| Last modified on | 2025/10/03 14:51:23 |
A Comparative Study of Anterior and Posterior Scales in a Questionnaire for the Assessment of Premenstrual Syndrome (PMS)
A Comparative Study of Anterior and Posterior Scales in a Questionnaire for the Assessment of Premenstrual Syndrome (PMS)
A Comparative Study of Anterior and Posterior Scales in a Questionnaire for the Assessment of Premenstrual Syndrome (PMS)
A Comparative Study of Anterior and Posterior Scales in a Questionnaire for the Assessment of Premenstrual Syndrome (PMS)
| Japan |
Healthy subjects
| Adult |
Others
NO
Identify differences in the way symptoms are expressed when assessed using an anteroposterior or retrospective scale.
Others
Exploratory study
Comparison of anterior and posterior scale questionnaires
(1)PMTS-VAS
(2)PMTS-SR
(3)DRSP
(4)Modified MDQ
(5)POMS-2 shortened version for adults
(6)Comparison of Likert Scale and Visual Analog Scale (VAS)
Observational
| 20 | years-old | <= |
| 45 | years-old | >= |
Female
(1)Women between 20 and 45 years of age at the time of obtaining consent to participate in the study
(2)Subjects with subjective symptoms of PMS
(3)Menstrual cycle of 25 to 38 days
(4)Those whose most recent menstrual period was between 13 and 20 days at the time of the first survey distribution.
(5)Those who have been fully informed of the purpose and content of this study, have the capacity to consent, and who volunteer of their own free will with full understanding, and whose consent can be obtained through electromagnetic informed consent.
(1)Menopausal women
(2)Currently using medications that affect ovulation (oral contraceptives (birth control pills), ovulation suppressants, hormonal agents)
(3)Who are currently receiving treatment or medication by a physician for a gynecological disorder (menopause, hormone replacement therapy, uterine, ovarian, or mammary gland disease, etc.)
(4)Who are currently receiving treatment or medication by a physician for a mental disorder (depression, anxiety, insomnia, panic disorder, etc.)
(5)Women who are currently pregnant.
750
| 1st name | Soma |
| Middle name | |
| Last name | Ohde |
Macromill, Inc.
Unit Manager, Clinical Research Business Unit, Life Science Division
108-0075
Shinagawa East One Tower. 11F, 2-16-1 Konan, Minato-ku, Tokyo, JAPAN
070-3155-1692
ohde@macromill.com
| 1st name | Yuki |
| Middle name | |
| Last name | Mori |
Macromill, Inc.
Life Science Division
108-0075
Shinagawa East One Tower. 11F, 2-16-1 Konan, Minato-ku, Tokyo, JAPAN
080-5186-5400
yuk_mori@macromill.com
Macromill, Inc.
Macromill, Inc.
Profit organization
User Life Sciences Ethics Review Committee, Inc.
372-3 Nibo, Iizuka-shi, Fukuoka
0948-82-3123
userlifescience.bm@gmail.com
NO
| 2025 | Year | 03 | Month | 31 | Day |
Unpublished
Completed
| 2025 | Year | 03 | Month | 12 | Day |
| 2025 | Year | 03 | Month | 26 | Day |
| 2025 | Year | 03 | Month | 31 | Day |
| 2025 | Year | 04 | Month | 17 | Day |
-
| 2025 | Year | 03 | Month | 28 | Day |
| 2025 | Year | 10 | Month | 03 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000065623